MIVUX®

MIVUX®
Product characteristics

Active substance: Lamivudine

Therapeutic group: Anti-infective agents for systemic use. Antiviral agents for systemic use. Direct-acting antiviral agents. Nucleoside and nucleotide reverse transcriptase inhibitors. Lamivudine. ATC code J05AF05

Form: 14 tablets per blister pack. 2 blister pack per cardboard box.

Package Type: Film-coated tablets, 100 mg

Download instruction
˄